EMHTF - Emerald Health Therapeutics GAAP EPS of -C$0.19 revenue of C$11.9M July, 05 2022 12:30 AM Emerald Health Therapeutics Emerald Health Therapeutics press release ( OTCQX:EMHTF ): FY GAAP EPS of -C$0.19. Revenue of C$11.9M (-16.5% Y/Y). For further details see: Emerald Health Therapeutics GAAP EPS of -C$0.19, revenue of C$11.9M